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Abstract 
Qatar has a high burden of chronic diseases including obesity, car-
diovascular disease and type 2 diabetes mellitus. Low serum vitamin D
levels have been implicated in the development and progression of a
range of these chronic conditions. The prevalence of vitamin D insuf-
ficiency or deficiency in the general population of Qatar has still not
been investigated. The aim of this study was to carry out a systematic
review of published studies documenting the prevalence of vitamin D
insufficiency or deficiency in the Qatari population. A search strategy
was developed for online databases (PubMed, Ovid MEDLINE, Embase
and Embase Classic) between 1980 to the last week of August 2012,
and bibliographies of the included studies were further searched for
additional reports. Search terms used were QATAR and VITAMIN D.
Studies reporting the serum levels of vitamin D in several Qatari sub-
populations were identified. Weighted-average vitamin D serum levels
and prevalence of low vitamin D status (<75 nmol/L) were calculated.
Subgroup analysis was carried out by age. The quality of each study
was evaluated according to four criteria: national representativeness,
representation of males and females, the sample size, and the sam-
pling protocol. A total of 16 relevant publications were identified, and
8 of these (reporting from 7 unique studies) met our inclusion and
exclusion criteria with a total number of 1,699 Qatari subjects. The
pooled sample size weighted-average vitamin D concentration (±SD)
was 45.3±14.3 nmol/L (95% CI: 44.6-46.0; range 29.2-66.9 nmol/L). The
weighted-average prevalence of low vitamin D status was 90.4% (95%
CI: 90.1-91.0; range 83%-91%). Age was inversely correlated with vita-
min D levels and directly with its insufficiency/deficiency prevalence.
There have only been a few studies on the prevalence of low vitamin D
in Qatar a very high prevalence of vitamin D insufficiency/deficiency
in Qatar that increases with age has been suggested. The present
report underlines the need to develop a nationally representative study
to further evaluate vitamin D status in Qatar. Given the growing evi-
dence of the role of vitamin D in chronic disease, this study could help
develop public health strategies for disease prevention in Qatar. 
Introduction
It has recently been reported that member states of the Gulf
Cooperative Council (GCC, Bahrain, Kuwait, Oman, Qatar, Saudi
Arabia and the United Arab Emirates) have a higher burden of chron-
ic diseases [e.g., metabolic syndrome, type 2 diabetes mellitus
(T2DM), obesity, and cardiovascular diseases] than most developed
countries.1,2 Qatar has one of the highest prevalence rates of obesity
among all GCC countries after Kuwait, and is ranked sixth globally;
45.3% of the entire Qatari population is obese.3 Qatar was also report-
ed to have the highest rate of obesity among boys in the Middle East
and North African region.2,4 Furthermore, according to recent esti-
mates,1,2,4 Qatar has high prevalence rates of hypertension (32%),
metabolic syndrome (27%), hyperglycemia (13%), diabetes and cardio-
vascular diseases (approx. 240 cases/100,000 for both conditions)5
among other countries in the Middle East, North Africa and the
Eastern Mediterranean Region.1,2,4,6,7
The increasing rate of non-communicable diseases in Qatar, as with
other GCC states, is believed to be influenced by genetic predisposi-
tion8,9 and the rapid socio-economic growth that has led to a more
sedentary lifestyle.10,11 Furthermore, several reports have highlighted a
growing pattern of an unhealthy diet and micronutrient deficiency as
major factors in the increasing incidence of metabolic derangements
and, subsequently, metabolic syndrome-related chronic diseases.2,4,11-14
In this context, vitamin D hypovitaminosis has received particular atten-
tion.11 The consensus of available information implicates low serum
vitamin D levels as a factor influencing the development of a range of
chronic conditions, such as metabolic syndrome, insulin resistance, type
2 diabetes mellitus and cardiovascular diseases.15-18 These findings are
supported by observations from populations around the world, including
the US,19 Europe,20 New Zealand21 and Asia,22 and are thought to be
related to the immunomodulatory function of vitamin D.23 Although egg
yolks, seafood oil, oily fish, and beef liver, together with fortified food,
are the major dietary sources of vitamin D, it is more readily accessible
through exposure to sunlight.24 However, several studies show that vita-
min D insufficiency can be quite prevalent even in sunny regions of the
world.11,25-28 In the sunny Gulf region, numerous reports have demon-
strated a high prevalence of low vitamin D status.2,11 In fact, the Gulf
region has some of the highest vitamin D insufficiency rates in the
world29 and Qatar is thought to have one of the highest vitamin D defi-
ciency/insufficiency rates. The high prevalence of low vitamin D status
in the Gulf region is believed to be due to several socio-cultural and
other factors, e.g. avoiding the sun during the summer months in order
to maintain a fair complexion (particularly among women), the intense
heat, the habit of not fortifying dairy products, and incorrect supplemen-
tation.2-4,11-14 Genetic predisposition to lower serum vitamin D synthesis
Significance for public health
Low serum vitamin D levels have been implicated in the development and
progression of a range of chronic conditions. A few studies have evaluated
the prevalence of low vitamin D status in Qatar and how this possibly caus-
es chronic disease. The limited information available suggests a high preva-
lence of vitamin D insufficiency/deficiency in Qatar and reinforces the need
to develop a nationally representative study to further evaluate vitamin D
status in the Qatari population. Subsequently, the present report could help
develop public health strategies for disease prevention in Qatar.
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and skin pigmentation may also play a role in vitamin D deficiency. For
example, it was shown that subjects of Asian origin exhibit lower serum
levels of vitamin D compared to their Caucasian counterparts even when
they are exposed to the same amount of sunlight.18 In Qatar, as with
other GCC states, there is an apparent coincidence of a unique lifestyle,
heterogeneous population genetics, low vitamin D intake/exposure, and
a high prevalence of obesity, type 2 diabetes mellitus, and cardiovascular
and other chronic diseases. To better understand the mechanisms by
which these chronic disorders develop, it is essential to examine the eti-
ological role of vitamin D deficiency. Before any relationship can be con-
firmed, the extent of vitamin D insufficiency or deficiency in Qatar must
be accurately evaluated. The present review was undertaken in an
attempt to systematically examine the published evidence on the preva-
lence of vitamin D insufficiency or deficiency in the Qatari population.
Defining the magnitude of this health problem will allow effective public
health strategies for chronic disease prevention and control to be
designed.
Design and methodsSearch strategy and inclusion criteria
A search was conducted in PubMed, Ovid MEDLINE, Embase and
Embase Classic databases between 1980 to the last week of August
2012 using the search term (MeSH) VITAMIN D and the keyword
QATAR. The search retrieved 27 English language studies (Figure 1).
After eliminating duplicate listings, and initial screening of the titles
and abstracts, a total of 16 peer-reviewed articles were selected and the
full articles were retrieved. A bibliography search did not identify any
additional studies. Inclusion criteria were limited to studies that
reported vitamin D levels in male and female subjects of all age groups
and in healthy populations (non-vitamin D deficient and defined as
healthy) from available social groups (e.g,. school children, health pro-
fessionals, athletes, students, etc.).
We excluded studies in which vitamin D was reported in subjects
with hypovitaminosis D,30,31 hypocalcemia32 or rickets.33 One study,
reported in 2 publications with different details, divided the population
into vitamin D sufficient (50-200 nmol/L) and deficient (<50 nmol/L)
with no mention of the average population levels:34,35 there was also
one review article.11 Another study was shown in 2 different reports36,37
and we excluded the earlier publication.36 Eight publications (from 7
unique studies) reported the level of vitamin D in their study popula-
tions and satisfied our selection criteria; these were included in the
review.37-44 From the studies included, 2 reports were considered as one
study42,43 since the same population and findings were presented again
(but with additional information) in the more recent report. From
these 2 studies,42,43 we examined vitamin D in healthy controls only
and excluded information from those children with asthma37 or dia-
betes.42,43Inter-reviewer agreement 
The abstracts of the selected studies were independently reviewed by
2 readers (AB and BG-B). Differences were resolved through discus-
sion until a consensus was reached. As stated above, only 7 unique
studies (from 8 reports) were reviewed according to the selection cri-
teria. Percentage agreement and Cohen’s Kappa (k) statistic45 were
calculated and interpreted in accordance with Landis and Koch’s
benchmarks46 for assessing the agreement between reviewers as poor
(<0), slight (0.0-0.20), fair (0.21-0.40), moderate (0.41-0.60), substan-
tial (0.61-0.80), and excellent (0.81-1.0). The agreement on the inclu-
sion between the two reviewers was 94%, with k=0.88.46
Definition of the vitamin D deficiency 
Optimal vitamin D effects on the skeleton and on calcium metabo-
lism are achieved at a serum 25-hydroxyvitamin D [25(OH)D] level of
more than 75 nmol/L.24 Vitamin D deficiency is defined as a serum
25(OH)D less than 50 nmol/L; insufficiency is considered at 51-75
nmol/L. For the purposes of this study, and clarity of presentation, we
categorised subjects with less than 75 nmol/L as vitamin D insuffi-
cient/deficient, though this definition would include those technically
deficient in vitamin D. Vitamin D concentrations were converted from
the reported ng/mL to nmol/L.Study subjects and data analysis
A total of 1767 healthy subjects from Qatar (i.e. Qatari nationals and
expatriates) were included from the 8 selected reports from 7 stud-
ies.37-44 There were 795 males (46.8%) and 904 females (53.2%) and
the male-to-female ratio was 1:1.14. There were 68 missing subjects
(not reported by gender) from 2 studies: 19 subjects were missing from
the study by Bener et al.37 and 46 subjects were missing from the study
by El-Manyar et al.44 Therefore, 1699 subjects were evaluated in this
study. We determined the weighted-overall average and weighted aver-
age age-related vitamin D serum concentrations, and prevalence esti-
mates for vitamin D insufficiency/deficiency and 95% confidence inter-
vals (95% CI) by pooling values from studies meeting the selection cri-
teria and calculating averages weighted by sample size as previously
described.47Assessment of the methodological quality of studies
The methodological quality of each study was evaluated as previous-
ly described1 with some modification. Quality of the study was based on
four criteria: national representativeness, equal representation of both
sexes, robustness of the sample size (at least 400 subjects), and an
explicit sampling protocol. For each criterion, each study was given a
score (0 or 1, with 1 being high quality). The total score was calculated
for each study (score range 0-4). Quality scores of 4, 3, 2 or 1 were con-
sidered excellent, good, fair or poor, respectively.
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Figure 1. Systematic literature review process. The flow diagram
describes the systematic review of literature on vitamin D status
in Qatar. The selected 8 reports represent 7 unique studies.
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ResultsSelected studies and study populations
Eight studies met our inclusion and exclusion criteria. The progres-
sion of studies through the search and selection process is illustrated
in Figure 1. The selected studies were carried out on different Qatari
sub-populations including children (<16 years old), health care profes-
sionals, sportsmen and female college students, as well as retrospec-
tively from hospital records (Table 1). The weighted-average age of the
studied sub-populations was 27.7±14.3 years (95% CI: 8.7-37.2). The
number of subjects examined in each of these studies ranged from 64
to 498 with an almost equal gender representation (overall male-to-
female ratio 1:1.14). The samples in these studies were collected
between winter 2007 to fall 2010; one study did not state the duration
of recruitment.39
None of the selected studies were drawn from a nationally- or geo-
graphically-representative sample. Therefore, none scored the full 4
points assigned for quality assessment. Two studies scored 3 out of 4
quality points and were considered to be of a good quality since they
reported an almost equal gender representation, large sample size
(>400 subjects), and an explicit sampling methodology. Two studies
were of fair quality while the remaining 3 reports were considered poor
(Table 1). Despite their scoring, the 3 poor reports were included in the
present study to avoid any selection bias and to ensure a comprehen-
sive evaluation of the prevalence of vitamin D insufficiency in Qatar.Vitamin D levels and deficiency prevalence 
The pooled sample size weighted-average level of vitamin D in the
Qatari sub-populations studied was 45.3±14.3 nmol/L (95% CI: 44.6-
46.0) (Table 2). This estimate was generated from 4 studies with a
sample size of 1,472 subjects. Three studies did not report the average
vitamin D serum levels in the study population.38-40 The weighted-aver-
age prevalence of vitamin D insufficiency/deficiency (<75 nmol/L) was
90.4% (95% CI: 90.1-91.0), an estimate that was calculated from the 7
selected studies (n=1,699). In general, the vitamin D serum levels
ranged from 29.2 to 66.9 nmol/L and the prevalence of vitamin D defi-
ciency in the sub-populations studied ranged between 83% and 91% if
the 3 studies with low quality score were excluded.Vitamin D in different age groups
The selected studies spanned three main age groups: under 16 years
of age (3 studies from 4 reports),37,39,42,43 16-30 years of age (2 studies)
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Table 2. Average vitamin D serum levels and deficiency/insufficiency in the Qatari population at different age groups.
Age group Study Study Average serum vitamin D levels Prevalence of vitamin D <75nmol/L 
Years* n n (nmol/L) (%)
<16 698 Bener et al.42,43# 170 46.2±23.0 85
Bener et al.37 464 66.9±24.7 83
Racinais et al.39 64 NS 100
Weighted average§ (60.6-62.2) (85.9-86.4)
61.4±10.0 86.2±2.4
16-30 163 Hamilton et al.40 92 NS 100
Shrief and Rizk38 71 NS 97
Weighted average ^ 93.9±5.3
(93.5-94.3)
>30 838 Mahdy et al.41 340 29.2 97
El-Menyar et al.44 498 35.9±27.5 91
Weighted average 33.2±3.4 93.4±3.1
(31.9-32.5) (93.1-93.6)
O verall° 1699 Weighted overall average 45.3±14.3$ 90.4±7.2**
(44.6-46.0) (90.1-90.8)
*Stratifying vitamin D level by age was carried out from the average age of the study population (Table 1). Stratifying vitamin D level by gender from the selected reports was not possible given the way in which the
data were in the original studies. °Overall represents the entire age range from <16 to >30 years.#The same study reported in two publications, with additional information in the more recent report. §Data represent
weighted average±standard deviation (SD). Numbers in parentheses are 95% confidence intervals (CI) for weighted average. ^Data in three of the selected studies (ref. ns. 38-40) did not allow this value to be gen-
erated. $Calculated from 1472 subjects extracted from 4 of the selected studies in which the relevant information was available (ref. ns. 37, 41-44). **Calculated from the 7 selected studies (n=1699).  NS, values not
stated in the original report.
Table 1. Characteristics of the selected studies and study populations.
Study Study Study Duration n Average age M:F (%) Quality 
population design of recruitment (years±SD)* score°
Bener et al.42,43# Children Case-control Aug-Dec 2007 170 9.9±4.2 47:53 2
Bener et al.37 Children Case-control Oct 2009-July 2010 464 8.01±4.6 55:45 3
Mahdy et al.41 Health care professionals Cross-sectional Jan 2007-Jan 2008 340 37.9§ 40:60 2
El-Menyar et al.44 Hospital record Retrospective Jan 2008-Nov 2009 498 49±13 44:56 3
Hamilton et al.40 Sportsmen Cross-sectional April-Oct 2008 92 21.3±6.9 100:0 1
Shrief and Rizk38 College girls Cross-sectional Spring-fall 2010 71 23^ 0:100 1
Racinais et al.39 School girls Cross-sectional NS 64 11.7±1.5 0:100 0
*Values represent mean±standard deviation (SD). °Quality score was calculated as described in Materials and Methods. #The same study reported in two publications, with additional information in the more recent
report. §SD was not mentioned in the original report. ^Median age as calculated from the reported age range. NS, not stated in the original report.
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38,40 and over 30 years of age (2 studies).41,44 We estimated the weight-
ed-average vitamin D serum concentration and prevalence of insuffi-
ciency/deficiency in each of these age groups (Table 2). Age group was
inversely correlated with vitamin D serum concentration (Spearman’s
correlation coefficient r=approx. 0.803; 95% CI: 0.79-0.82) and directly
with the prevalence of vitamin D insufficiency/deficiency (r=0.26; 95%
CI: 0.22-0.30). Vitamin D concentration was approximately 50% lower
in the oldest age group compared to the youngest. This was accompa-
nied by an increased prevalence of insufficiency/deficiency (86.2%-
93.4%) in the youngest and oldest groups, respectively.
Discussion
There are few published reports on vitamin D status in Qatar.
However, given the limited number of studies available, and despite the
heterogeneity of the characteristics (subject age, social group, study
design and study quality) of studies included in this review (Table 1),
there was an overall consensus on the presence of low vitamin serum
levels and high prevalence of its insufficiency/deficiency in Qatar.
Approximately 90% of the population had 25(OH)D levels below the
optimal level (weighted-average level 45.3±14.3 nmol/L) (Table 2). As
advocated by the National Academy of Sciences Institute of Medicine
(IOM), the optimal level of serum vitamin D is over 75 nmol/L with lev-
els around 50-75 nmol/L considered insufficient.24 None of the studies
found were geographically- or demographically-representative so an
accurate estimate of national vitamin D insufficiency/deficiency for
Qatar can not be made. However, based on the evidence generated from
this systematic review, about 90% of the Qatari population may have
insufficient levels of serum vitamin D. This estimate is similar, if not
higher, than that reported from other Arab and Gulf countries.2,11,29
Prevalence among adolescent Saudi girls and women indicates the
severity of the insufficiency with up to 80% presenting with vitamin D
levels below 25 nmol/L48 (Table 3). A similar prevalence of vitamin D
deficiency was also reported in UAE women.49,50 Furthermore, in Saudi
Arabian subjects with back pain, 83% had vitamin D levels below 22.5
nmol/L.51 Similar severe deficiency was also reported from Kuwait.52 As
stated above, this high prevalence of low vitamin D status is thought to
be linked to socio-cultural factors, the habit of not fortifying dairy prod-
ucts, and poor vitamin D supplementation.2,4,11-14
The rates of vitamin D insufficiency/deficiency reported in Qatar and
many GCC states, and in many population groups within nations at
high latitude (i.e. in the northern hemisphere in countries with little
sun exposure) are markedly higher than in many Western countries. In
Canada, for example, approximately 70% of the population is vitamin D
insufficient.53 However, in the United States, approximately 60% of the
population were found to have sufficient levels of vitamin D whereas
25% were at risk of vitamin D insufficiency and 8% were deficient54
(Table 3). Ethnic minority groups (originally from Arab countries) liv-
ing in northern Europe, the USA and Australia have also shown a high
prevalence of low vitamin D status.55 For example, over 80% of the
Moroccan women immigrants in the Netherlands had less than 25
nmol/L of 25(OH)D, rates that are similar to those reported in veiled
women in Australia.55 Comparison between the frequencies of vitamin
D deficiency in Qatar can also be made with those reported in the home
countries of major population sub-groups present in Qatar. For exam-
ple, a large proportion of the expatriates in Qatar are from southern
and eastern Asia. Analysis of vitamin D in women of reproductive and
post-menopausal ages from southern India showed that the frequency
of deficiency can reach 76% and 70% in these two groups, respective-
ly.56 These frequencies are still lower than those reported in the Qatari
population but higher than those from the USA and Canada (Table 3). 
Several studies16,23,57-61 showed an inverse association between
serum 25(OH)D and a wide array of chronic diseases, such as cancer,
autoimmune disorders, atherosclerosis, and cardiovascular diseases.
Furthermore, an inverse relationship was recently reported between
vitamin D serum levels and a number of chronic disease-predisposing
conditions such as metabolic syndrome,18 insulin resistance,62 car-
diometabolic diseases,63 and obesity.64 This suggests that vitamin D
insufficiency/deficiency may play a role at the early stages of the natu-
ral history of many chronic diseases.23 Vitamin D deficiency may, there-
fore, explain, at least partially, the increased incidence of hypertension,
metabolic syndrome, hyperglycemia, obesity, diabetes and cardiovascu-
lar diseases in Qatar. Indeed, other host-related (e.g. genetic profile),
environmental (e.g. sedentary lifestyle and diet), and social and eco-
nomic (e.g. religion and economic growth) factors may work together
to contribute to the increased rates of chronic disease not only in Qatar,
but also in other countries with similar ancestral and socio-economic
profiles.1,2,4,6,7,11
Age was inversely associated with vitamin D serum levels and direct-
ly with the prevalence of its deficiency in the sub-populations studied
(Table 2). This observation is supported by various reports demonstrat-
ing lower vitamin D serum concentrations with increased age, as well
as higher insufficiency/deficiency rates in the oldest age group com-
pared to the youngest. For example, in healthy Saudi men in the over
50 years age group, 12% were deficient (compared to 10% in the
younger age group) and 25% had insufficient 25(OH)D levels (com-
pared to 18% in the younger men).65 Furthermore, in the United States,
a recent study from the National Health and Nutrition Examination
Survey (NHANES) reported that the prevalence of vitamin D deficiency
is lower younger people whereas serum 25(OH)D is higher.54 Similarly,
in the Canadian Health Measure Survey (CHMS) population, children
aged 6-11 years were most likely to be above the adequacy cut-off val-
ues compared to the older adults.66 According to CHMS data, younger
age groups were found to be more likely to consume vitamin D fortified
dairy products (e.g. milk) compared to the older age groups. In addi-
tion, the increased obesity rates in adult population may be partially
responsible for this age-related difference in vitamin D levels. Low
plasma 25(OH)D concentrations are known to be common in obese
subjects and a negative relationship with body fat distribution has been
recently reported.67 This is thought to be due to the sequestration of
vitamin D, as a fat-soluble micronutrient, in the adipose tissue in
obese individuals.23,67 Furthermore, vitamin D deficiency may play a
role in the development of asthma, rickets in children, and osteomala-
cia in adults. Rickets is currently largely found in some low-income
countries in Africa, Asia or the Middle East,68 as well as in subjects with
the pseudo-vitamin D deficiency rickets genetic disorders.69
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Table 3. Prevalence of vitamin D insufficiency/deficiency in some
Arab and Western countries and in Qatar. 
Country Study group Prevalence of low vitamin D (%)
Qatar Population (this study) 90
Jordan Adult females 37
Morocco Adult females 91
Lebanon Adolescent females 32
Adolescent males 12
Saudi Arabia Adolescent females 80
Tunisia Adult females 48
USA Population 31
Canada Population 70
Data were extracted from the findings of the present study (for Qatar) and from the literature.2,3,48,53,54
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Osteomalacia  (a bone-thinning disorder) occurs exclusively in adults
and is thought to contribute to chronic musculoskeletal pain.68,69
Individuals with this bone disorder benefit from vitamin D supple-
ments with calcium. Although there is some evidence to suggest a link
between vitamin D and asthma, particularly in children,36,37 the bene-
ficial effect of supplements is still a question for debate70 and further
research is warranted to confirm the etiological role of vitamin D in
asthma. 
The present study has some limitations and any interpretation of
results should bear this in mind. Our findings are based on only a small
number of studies (only 8 reports from 7 unique studies). These stud-
ies are not of exceptional quality, different study designs had been
adopted, and diverse Qatari sub-populations had been studied with a
wide age range. Furthermore, none of the selected studies were drawn
from a nationally- or geographically-representative sample.
However, it is the first systematic review of the levels of vitamin D
and the extent of its insufficiency/deficiency in Qataris. Furthermore,
while the evidence base is limited, this review is the first to report that,
in Qatar, such vitamin D insufficiency/deficiency is associated with
age. The present report illustrates a gap in the knowledge on vitamin D
in Qatar and reinforces the need for a nationally representative study
to assess vitamin D status and its association with a range of chronic
diseases known to occur at high incidence rates in Qatar. In Qatar, vita-
min D should be introduced into public health intervention strategies
for chronic disease prevention, and changes in lifestyle and diet should
be promoted. 
Current practices for the prevention of diseases related to vitamin D
insufficiency (e.g., type 2 diabetes mellitus, cardiovascular diseases
and osteomalacia) in the general population include changes in
lifestyle and diet, and exercise. Vitamin D supplements may help pre-
vent and control these conditions through its anti-oxidant, anti-inflam-
matory and immunomodulatory properties.23,58 Therefore, it is reason-
able to suggest that the two preventive approaches (i.e. vitamin D sup-
plements and changes in lifestyle) may be combined into a single pub-
lic health programme to enhance the success and effectiveness of
intervention.57,58 This strategy could be more efficient in reducing the
pre-clinical disease status and, subsequently the disease burden, than
when a single approach is considered. Furthermore, such a combined
strategy can be introduced into general practice settings as well as in a
population-based fashion with low expenditure and minimal side
effects. This approach should principally target subjects with vitamin D
insufficiency when considering the socio-cultural factors contributing
to the low vitamin D status, e.g. women, children, and obese or heavy-
weight subjects. 
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